Skip to content

Learn How to Pronounce secukinumab

Quick Answer: In English, the drug secukinumab is pronounced /ˌsɛkjuːˈkɪnjʊmæb/ in both US and UK English.
(Listen to the audio above for the stress and intonation)

The Expert's Take

Dr. Franz Lang
"A former student, now in medical sales, recently joked about the "tongue-twisters" in her pharmacology portfolio. She cited "secukinumab" as a prime example, saying doctors often just say "Cosentyx" to avoid the tricky sequence of 'k', 'n', and 'm' sounds. It's a brilliant illustration of how brand names often win over generic ones purely on phonetic ease, despite the scientific precision of the original term."
By Dr. Franz Lang

Meaning and Context

Secukinumab is a fully human monoclonal antibody biologic medication that represents a significant advancement in the treatment of several chronic autoimmune conditions. Specifically designed to selectively bind to and neutralize interleukin-17A (IL-17A), a key pro-inflammatory cytokine, it disrupts the inflammatory cascade responsible for the symptoms of plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. Approved by the U.S. Food and Drug Administration (FDA) in 2015 for moderate-to-severe plaque psoriasis, its indications have since expanded, making it a cornerstone therapy in dermatology and rheumatology. Marketed globally under the brand name Cosentyx, this injectable drug offers a targeted mechanism of action, providing substantial skin clearance and joint symptom relief for patients who may have had inadequate responses to conventional systemic treatments or other biologics. Its role in managing these immune-mediated diseases underscores the importance of precision medicine in improving quality of life and long-term outcomes for patients.

Common Mistakes and Alternative Spellings

The spelling "secukinumab" follows a standardized convention for monoclonal antibody nomenclature, where the suffix "-mab" indicates its classification. Common misspellings and typographical errors often arise from phonetic interpretation or keyboard slips. Frequent variations include "secukinumap" (substituting 'b' with 'p'), "secukinamab" (adding an extra 'a'), and "seculinumab" (replacing the 'k' with an 'l'). Another common error is "Cosentyx," the brand name, being misspelled as "Cosentryx," "Cosentix," or "Cosenytx." In professional and patient communications, ensuring the correct spelling is crucial for accurate prescription, medical literature searches, and insurance processing. The non-proprietary name is consistently spelled as secukinumab across regulatory documents and scientific literature.

Example Sentences

After several conventional therapies failed to control her severe plaque psoriasis, her rheumatologist initiated treatment with secukinumab, leading to a dramatic improvement in skin lesions within weeks.

Clinical trials have consistently demonstrated that secukinumab is highly effective in reducing the symptoms of active ankylosing spondylitis, including spinal pain and stiffness.

When prescribing Cosentyx, the healthcare provider must counsel the patient on proper subcutaneous injection techniques for self-administration of secukinumab.

The drug's targeted action on interleukin-17A makes secukinumab a preferred choice for patients with comorbid psoriatic arthritis and psoriasis.

A key consideration in the long-term management plan is monitoring for potential side effects, such as an increased risk of infections, while on secukinumab therapy.

Sources and References

I researched the pronunciation of this pharmaceutical name by consulting the medical and general pronunciation resources available. I found an audio recording on Forvo, which is a reliable source for hearing words spoken by native speakers. The detailed monograph on Drugs.com provided the standard medical context and likely pronunciation guidelines. I also cross-referenced the spelling and usage on the English Wikipedia and Wiktionary entries to confirm its standard form.

Related Pronunciations



📂 Browse all words in the Drugs, Molecules and Vaccines category ➔